| Literature DB >> 25693168 |
Jatinder Kumar1, Priyanka Dhar1, Amol B Tayade1, Damodar Gupta2, Om P Chaurasia1, Dalip K Upreti3, Kiran Toppo3, Rajesh Arora4, M R Suseela3, Ravi B Srivastava1.
Abstract
The freshwater alga Spirogyra porticalis (Muell.) Cleve, a filamentous charophyte, collected from the Indian trans-Himalayan cold desert, was identified on the basis of morpho-anatomical characters. Extracts of this alga were made using solvents of varying polarity viz. n-hexane, acetonitrile, methanol and water. The antioxidant capacities and phenolic profile of the extracts were estimated. The methanol extract showing highest antioxidant capacity and rich phenolic attributes was further investigated and phytochemical profiling was conducted by gas chromatography-mass spectrometry (GC/MS) hyphenated technique. The cytotoxic activity of methanol extract was evaluated on human hepatocellular carcinoma HepG2 and colon carcinoma RKO cell lines. The anti-hypoxic effect of methanol extract of the alga was tested on in vivo animal system to confirm its potential to ameliorate oxidative stress. The antioxidant assays viz. ferric reducing antioxidant power (FRAP), 2,2'-azinobis-(3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt (ABTS), 1,1-diphenyl-2-picrylhydrazyl (DPPH) and nitric oxide (NO) radical scavenging capacities, β-carotene-linoleic acid bleaching property and lipid peroxidation exhibited analogous results, wherein the algal extracts showed significantly high antioxidant potential. The extracts were also found to possess high content of total proanthocyanidin, flavonoid and polyphenol. GC/MS analysis revealed the presence of thirteen chemotypes in the methanol extract representing different phytochemical groups like fatty acid esters, sterols, unsaturated alcohols, alkynes etc. with substantial phyto-pharmaceutical importance. The methanol extract was observed to possess anticancer activity as revealed from studies on HepG2 and RKO cell lines. In the present study, S. porticalis methanol extract also provided protection from hypoxia-induced oxidative stress and accelerated the onset of adaptative changes in rats during exposure to hypobaric hypoxia. The bioactive phytochemicals present in this trans-Himalayan alga are of enormous interest and can be utilized sustainably for discovery of novel drugs against oxidative stress.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25693168 PMCID: PMC4333294 DOI: 10.1371/journal.pone.0118255
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Morphology of S. porticalis under Leica DM500 research microscope.
Antioxidant capacities of S. porticalis extracts .
| Antioxidant capacity | SWE | SME | SAE | SHE |
|---|---|---|---|---|
| FRAP (mM Fe (II)/g extract) | 32.69 ± 3.86 | 171.49 ± 19.25 | 137.70 ± 11.16 | 18.91 ± 1.46 |
| ABTS IC50 (mg/ml) | 37.71 ± 0.09 | 3.48 ± 0.11 | 24.73 ± 0.09 | 4.68 ± 0.11 |
| β-carotene IC50 (mg/ml) | 0.43 ± 0.01 | 0.20 ± 0.00 | 11.23 ± 0.10 | 0.33 ± 0.02 |
| DPPH IC50 (mg/ml) | 8.06 ± 0.10 | 0.52 ± 0.01 | 5.23 ± 0.11 | 10.94 ± 0.08 |
| NO IC50 (mg/ml) | 9.54 ± 0.09 | 4.31 ± 0.11 | 61.11 ± 0.11 | 31.47 ± 0.08 |
| Lipid peroxidation IC50 (mg/ml) | 1.38 ± 0.11 | 0.06 ± 0.01 | 0.42 ± 0.00 | 0.33 ± 0.01 |
aMean ± SD of three replicates.
SWE: S. porticalis water extract, SME: S. porticalis methanol extract, SAE: S. porticalis acetonitrile extract, SHE: S. porticalis n-hexane extract.
p<0.05
*compared with SWE
#compared with SME
$compared with SAE
Total phenolic (TPC), flavanoid (TFC) and proanthocyanidin content (TPAC) in S. porticalis extracts from Indian trans-Himalaya .
| Phytochemicals | SWE | SME | SAE | SHE |
|---|---|---|---|---|
| TPC (mg GAE/ g) | 14.90 ± 1.26 | 96.70 ± 9.64 | 21.42 ± 1.07 | 23.72 ± 2.5 |
| TFC (mg QE/g) | 13.82 ± 1.36 | 37.59 ± 2.80 | 34.76 ± 2.99 | 35.30 ± 3.02 |
| TPAC (mg CE/g) | 25.51 ± 2.25 | 122.55 ± 10.12 | 78.36 ± 5.78 | 94.79 ± 7.74 |
aMean ± SD of three replicates.
SWE: S. porticalis water extract, SME: S. porticalis methanol extract, SAE: S. porticalis acetonitrile extract, SHE: S. porticalis n-hexane extract.
p<0.05
*compared with SWE
#compared with SME
$compared with SAE
Fig 2GC/MS chemometric profile of S. porticalis methanol extract.
Algal chemotypes identified in methanol extract of S. porticalis by GC/MS.
|
|
|
|
|
|
|
|
| |
|---|---|---|---|---|---|---|---|---|
| 1 | 15.78 | 156723 | 0.20 | Unknown | - | - | - | - |
| 2 | 17.00 | 257237 | 0.34 | Dihydroactinidiolide | C11H16O2 | 180 | 15356–74–8 | Antibacterial; antiproliferative; cytotoxic |
| 3 | 19.24 | 335417 | 0.43 | 1,5-hexadien-3-ol, 3-methyl-6-(methylthio)-1-(2,6,6-trimethyl-1-cyclohexen-1-yl) | C17H28OS | 280 | 97369–78–3 | - |
| 4 | 20.53 | 422013 | 0.55 | Loliolide | C11H16O3 | 196 | 5989–02–6 | Strong anti-repellent; antioxidant; protective effects against H2O2-induced cell damage |
| 5 | 21.16 | 6137430 | 8.05 | 8-Hexadecyne | C16H30 | 222 | 19781–86–3 | Used in the preparation of fatty alcohols with potential for application in commercial products like as bio-diesel, lubricants, greases and cosmetics |
| 6 | 21.76 | 7509928 | 9.82 | 5,8,11,14,17-Eicosapentaenoic acid, methyl ester, (all-Z)- | C21H32O2 | 316 | 2734–47–6 | Hypolipidemic action; lipid-lowering effect; enhancing effect on hepatic biliary secretion; anti-arteriosclerotic |
| 7 | 21.95 | 791387 | 1.02 | 3-Heptadecen-5-yne, (Z)- | C17H30 | 234 | 74744–55–1 | - |
| 8 | 22.31 | 9034647 | 12.01 | Hexadecanoic acid, methyl ester | C17H34O2 | 270 | 112–39–0 | Antioxidant; nematicide; pesticide; lubricant; antiandrogenic; flavor, hemolytic 5-alpha reductase inhibitor; hypocholesterolemic |
| 9 | 23.88 | 5526076 | 7.26 | 4,7,10,13,16,19-Docosahexaenoic acid, methyl ester, (all-Z)- | C23H34O2 | 342 | 2566–90–7 | - |
| 10 | 24.43 | 16103379 | 21.32 | Ethyl Linoleolate | C20H36O2 | 308 | 544–35–4 | Antioxidant; lightens UV-induced skin pigmentation; anti-inflammatory; competitive inhibitor of prostaglandin production; wounds healing properties; effective anti-acne agent |
| 11 | 24.56 | 13175492 | 18.22 | 3,7,11,15-Tetramethyl-2-hexadecen-1-ol | C20H40O | 296 | 102608–53–7 | Used in manufacturing synthetic vitamins E and K; an ingredient of fragrances; end applications include soap, detergent, beauty care product, household product; cancer preventive properties |
| 12 | 26.29 | 945579 | 1.23 | Ethyl-5,8,11,14,17-icosapentaenoate | C22H34O2 | 330 | 84494–70–2 | It has lipid-lowering or hypolipidemic effects, provides protection against atherosclerosis and its complications, cardio-protective functions |
| 13 | 39.67 | 14709007 | 19.55 | Stigmasta-5,24(28)-dien-3-ol, (3 | C29H48O | 412 | 18472–36–1 | Androgenic; angiogenic; anorexic; antiadenomic; antiandrogenic; antibacterial; anticancer; antiedemic; antiestrogenic; antifeedant; antifertility; antigonadotrophic; antihyperlipoproteinaemic; anti-inflammatory, antileukemic |
Fig 3Cytotoxic effect of S. porticalis methanol extract on HepG2 and RKO cells.
Cytotoxicity of methanol extract of S. porticalis against HepG2 and RKO cells.
| Concentration (μg/ml) | Control (C) | HepG2 cells | RKO cells | ||||||
|---|---|---|---|---|---|---|---|---|---|
| After 24 h | After 48 h | After 72 h | After 24 h | After 48 h | After 72 h | After 24 h | After 48 h | After 72 h | |
| 333.33 | nt | nt | nt | d | d | d | d | d | d |
| 222.22 | nt | nt | nt | dfp | dep | dep | gapf | dsp | dfp |
| 148.15 | nt | nt | nt | nt | ga | ga | nt | gafp | nt |
| 98.77 | nt | nt | nt | nt | nt | nt | nt | nt | nt |
| 65.84 | nt | nt | nt | nt | nt | nt | nt | nt | nt |
| 43.90 | nt | nt | nt | nt | nt | nt | nt | nt | nt |
| 29.26 | nt | nt | nt | nt | nt | nt | nt | nt | nt |
nt: non-toxic, ga: growth arrested, gafp: growth arrested 50%, dfp: death 50%, dsp: death 70%, dep: death 80%, d: dead
Fig 4Microscopic images (10×10X) showing cell growth and morphology after 24 h treatment of S. porticalis extract in HepG2 and RKO cancer cells.
a. HepG2 cells with good growth, b. HepG2 cells with partially arrested or 50% arrested growth, c. HepG2 cells with arrested growth, d. HepG2 dead cells, e. RKO cells with good growth, f. RKO cells with partially arrested or 50% arrested growth, g. RKO cells with arrested growth, h. RKO dead cells.
Fig 5Changes in serum GSH, GSSG, GSH/GSSG and ROS level following administration of S. porticalis methanol extract during exposure to hypobaric hypoxia.
a. Changes in reduced glutathione level, b. Changes in the level of oxidised glutathione, c. Changes in GSH/GSSG level, d. Changes in reactive oxygen species generation. * denotes p≤0.05 when compared to normoxia, # denotes p≤0.05 when compared to normoxia + vehicle, $ denotes p≤0.05 when compared to hypoxia + vehicle.